Lifestyle
- Regular physical activity
- Stress management techniques
- Adequate hydration
- Sleep optimization
Aldosterone · Mineralocorticoid
Aldosterone quantifies the level of the mineralocorticoid hormone involved in sodium and potassium regulation.
Levels can vary with posture, time of day, and sodium intake.
Aldosterone (Aldo), a mineralocorticoid hormone produced by the adrenal glands, plays a crucial role in regulating sodium and potassium balance, as well as blood pressure. It acts primarily on the distal nephron of the kidney to promote sodium reabsorption and potassium excretion, thereby influencing fluid balance and systemic vascular resistance. Researchers have observed that aldosterone is a key component of the renin-angiotensin-aldosterone system (RAAS), which is activated in response to low blood volume or pressure. Clinically, aldosterone levels are significant in diagnosing and managing conditions such as primary aldosteronism, heart failure, and chronic kidney disease. Elevated aldosterone is often associated with hypertension and cardiovascular risk, while low levels may indicate adrenal insufficiency, such as Addison's disease. In the context of athletic performance and biohacking, aldosterone's role in fluid and electrolyte balance can impact endurance and recovery. Biohackers may monitor aldosterone to optimize hydration and electrolyte status, potentially enhancing performance and longevity. However, researchers found that aldosterone levels can be influenced by various factors, including time of day, posture, and dietary sodium intake. Testing should ideally be conducted in the morning and under standardized conditions to ensure accuracy. Additionally, certain medications, stress, and renal function can interfere with aldosterone measurements, necessitating careful interpretation of results.
Klinische Bedeutung
Elevated aldosterone levels indicate conditions like primary aldosteronism or secondary hyperaldosteronism, often associated with hypertension. Reduced levels suggest adrenal insufficiency, such as Addison's disease.
Progressively rising aldosterone suggests worsening hypertension or heart failure; re-test in 4 weeks if outside optimal range.
Falling aldosterone may indicate adrenal insufficiency or effective treatment of hyperaldosteronism.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before making significant dietary or lifestyle changes, especially if on medication.
Aldosterone levels peak in the morning; testing should be consistent in timing.
Testing Frequency
Annually for individuals with hypertension or adrenal disorders.
Correlated with
Current research suggests that the optimal aldosterone reference ranges and targets for specific populations, such as those with primary aldosteronism or cardio-kidney diseases, remain debated. Researchers have not yet established the full clinical implications of compensatory neurohormonal activation in patients on mineralocorticoid receptor antagonists. Additionally, unanswered clinical questions include the long-term effects of emerging aldosterone synthase inhibitors and the best strategies for monitoring disease progression in patients with primary aldosteronism.
846
Total Citations
6
Human/RCT
3.2
Avg. Influence
2024
Latest
Researchers conducted a meta-analysis on the effects of sodium-glucose cotransporter 2 inhibitors in people with type 2 diabetes. They found that these inhibitors reduce the risk of serious hyperkalemia without increasing the risk of hypokalemia.
This study evaluated the safety and pharmacokinetics of baxdrostat, an aldosterone synthase inhibitor, in healthy volunteers. Researchers observed a dose-dependent reduction in plasma aldosterone levels, indicating its potential for managing conditions associated with elevated aldosterone.
This study focused on hypoadrenocorticism in dogs, detailing its pathogenesis and diagnosis. Researchers found that immune-mediated destruction of adrenal glands leads to decreased hormone production, and diagnosis often requires specific hormone level testing.
Researchers explored the clinical significance of hyperkalemia associated with renin-angiotensin-aldosterone system inhibitors, noting it as a common adverse effect. The study emphasized the need for effective management strategies to mitigate hyperkalemia while allowing continued use of these beneficial medications.
This review explored the role of aldosterone in cardio-kidney diseases. Researchers observed that excess aldosterone contributes to inflammation and dysfunction in the heart and kidneys, and that mineralocorticoid receptor antagonists may mitigate these effects.
This study explored the role of the circadian clock gene PER1 in regulating blood pressure and sodium handling in mice. Researchers found that PER1 deficiency led to nondipping hypertension and inappropriate regulation of sodium transport genes, suggesting a link between circadian rhythms and blood pressure control.
This review analyzed the effects of finerenone, a new mineralocorticoid receptor antagonist. Researchers observed that it shows promise in treating cardiovascular and renal diseases, particularly in patients with type 2 diabetes and chronic kidney disease.
Researchers developed a new heptafluorobutyryl derivative of aldosterone for gas chromatography/mass spectrometry analysis. This method showed high sensitivity and stability, allowing for accurate measurement of aldosterone levels in serum. The findings were validated through agreement between results from two laboratories.
1
Total Trials
20
Total Enrolled
Assistance Publique - Hôpitaux de Paris
20
2024
relevant biomarkers strongly associated with primary lateralized hyperaldosteronism
Research publications about Aldosteron over time
10totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer